Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Effect of Withania somnifera on insulin sensitivity in non-insulin-dependent diabetes mellitus rats.

Anwer T, Sharma M, Pillai KK, Iqbal M.

Basic Clin Pharmacol Toxicol. 2008 Jun;102(6):498-503. doi: 10.1111/j.1742-7843.2008.00223.x. Epub 2008 Mar 16.

2.

Glucose control and insulin resistance in non-insulin-dependent diabetes mellitus.

Henry RR.

Ann Intern Med. 1996 Jan 1;124(1 Pt 2):97-103. Review.

PMID:
8554221
3.

Hyperinsulinemia and insulin resistance in hypertension: differential effects of antihypertensive agents.

Goyal RK.

Clin Exp Hypertens. 1999 Jan-Feb;21(1-2):167-79. Review.

PMID:
10052652
4.

Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.

Resmini E, Minuto F, Colao A, Ferone D.

Acta Diabetol. 2009 Jun;46(2):85-95. doi: 10.1007/s00592-009-0112-9. Epub 2009 Mar 26. Review.

PMID:
19322513
5.
6.
7.

Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part I).

O'Byrne S, Feely J.

Drugs. 1990 Jul;40(1):6-18. Review.

PMID:
2202583
8.

The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance.

Kirkham S, Akilen R, Sharma S, Tsiami A.

Diabetes Obes Metab. 2009 Dec;11(12):1100-13. doi: 10.1111/j.1463-1326.2009.01094.x. Review.

PMID:
19930003
9.

An integrated model for the glucose-insulin system.

Silber HE, Jauslin PM, Frey N, Karlsson MO.

Basic Clin Pharmacol Toxicol. 2010 Mar;106(3):189-94. doi: 10.1111/j.1742-7843.2009.00510.x. Epub 2009 Dec 29. Review.

11.

[alpha-Glucosidase inhibitor].

Ishida H.

Nihon Rinsho. 1999 Mar;57(3):669-74. Review. Japanese.

PMID:
10199152
12.

Non-insulin dependent diabetes mellitus: present therapies and new drug targets.

Das SK, Chakrabarti R.

Mini Rev Med Chem. 2005 Nov;5(11):1019-34. Review.

PMID:
16307531
13.

Efficacy and safety of 'true' cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis.

Ranasinghe P, Jayawardana R, Galappaththy P, Constantine GR, de Vas Gunawardana N, Katulanda P.

Diabet Med. 2012 Dec;29(12):1480-92. doi: 10.1111/j.1464-5491.2012.03718.x. Review.

PMID:
22671971
14.

The effect of Astragalus as an adjuvant treatment in type 2 diabetes mellitus: A (preliminary) meta-analysis.

Tian H, Lu J, He H, Zhang L, Dong Y, Yao H, Feng W, Wang S.

J Ethnopharmacol. 2016 Sep 15;191:206-215. doi: 10.1016/j.jep.2016.05.062. Epub 2016 Jun 3. Review.

PMID:
27269392
15.

Recommended testing in diabetes research.

Verspohl EJ.

Planta Med. 2002 Jul;68(7):581-90. Review.

PMID:
12142989
16.

Involvement of insulin-like growth factor-I in the control of glucose homeostasis.

Clemmons DR.

Curr Opin Pharmacol. 2006 Dec;6(6):620-5. Epub 2006 Oct 9. Review.

PMID:
17030015
17.

New pharmacological approaches to therapy of NIDDM.

Bressler R, Johnson D.

Diabetes Care. 1992 Jun;15(6):792-805. Review.

PMID:
1600838
18.

Oral hypoglycemic agents.

Lebovitz HE.

Prim Care. 1988 Jun;15(2):353-69. Review.

PMID:
3290924
19.

Vanadium salts and the future treatment of diabetes.

Shechter Y, Shisheva A.

Endeavour. 1993 Mar;17(1):27-31. Review.

PMID:
7686098
20.

[Therapeutic potential of vanadium in treating diabetes mellitus].

Sakurai H.

Clin Calcium. 2005 Jan;15(1):49-57. Review. Japanese.

PMID:
15632473

Supplemental Content

Support Center